Issuer disclosure record

$CRNX

Company name unavailable

Transactions involving this ticker in readable 2024 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $CRNX?

Open in trade feed →

purchaseRep. Josh GottheimerNJ-05

$CRNXCrinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Rep. Josh Gottheimer's filing reports that a joint account purchased · $1,001 – $15,000

View transaction source status →

Traded Sep 25, 2024Notified Oct 3, 2024Filed Oct 3, 20248 days to file

Owner: JointOriginal filing ↗